Mach7 Technologies (ASX:M7T) EBIT: A$-23.82 Mil (TTM As of Dec. 2025)


ASX:M7T Mach7 Technologies Ltd ASX:M7T
35 GF Score
Price A$0.31
GF Value A$0.82
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mach7 Technologies EBIT?

Mach7 Technologies ASX:M7T +3.39% 35 EBIT is A$-23.82 Mil as of Dec. 2025. GuruFocus rates ASX:M7T with a GF Score™ of 35/100 and a GF Value™ of A$0.82 (Possible Value Trap). The stock has 3 warning signs investors should review.

Mach7 Technologies's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was A$-5.69 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-23.82 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mach7 Technologies's annualized ROC % for the quarter that ended in Dec. 2025 was -27.03%. Mach7 Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -577.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -43.96%.

Mach7 Technologies  (ASX:M7T) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mach7 Technologies's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-11.38 * ( 1 - 0% )/( (45.981 + 38.222)/ 2 )
=-11.38/42.1015
=-27.03 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=64.209 - 2.357 - ( 23.069 - max(0, 14.409 - 30.28+23.069))
=45.981

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=54.037 - 2.099 - ( 18.488 - max(0, 11.894 - 25.61+18.488))
=38.222

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Mach7 Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-11.38/( ( (2.138 + max(-7.076, 0)) + (1.803 + max(-4.546, 0)) )/ 2 )
=-11.38/( ( 2.138 + 1.803 )/ 2 )
=-11.38/1.9705
=-577.52 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.837 + 0 + 3.278) - (2.357 + 11.834 + 1.7763568394003E-15)
=-7.076

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.29 + 0 + 2.832) - (2.099 + 0 + 9.569)
=-4.546

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-23.816/54.177
=-43.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mach7 Technologies EBIT Related Terms

Mach7 Technologies EBIT Historical Data

* Premium members only.

The historical data trend for Mach7 Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mach7 Technologies EBIT Chart

Mach7 Technologies Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.59 -6.28 -17.17 -22.34 -21.54

Mach7 Technologies Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.77 -16.57 -3.41 -18.13 -5.69

ASX:M7T vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, Mach7 Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mach7 Technologies EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's EV-to-EBIT falls into.


ASX:M7T
35GF Score
Mach7 Technologies Ltd ASX:M7T
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mach7 Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-23.82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of A$-23.82 Mil mean?
Mach7 Technologies (ASX:M7T) has a EBIT of A$-23.82 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Mach7 Technologies.
Is Mach7 Technologies' EBIT too high?
Mach7 Technologies' current EBIT is A$-23.82 Mil. Overall, Mach7 Technologies has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mach7 Technologies' EBIT compare to VEEV and BTSG?
Mach7 Technologies' EBIT of A$-23.82 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Mach7 Technologies. Mach7 Technologies's current EBIT is A$-23.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mach7 Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mach7 Technologies (ASX:M7T) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.82, compared to a current price of A$0.31 — trading 62.8% below its estimated fair value. The current EBIT is A$-23.82 Mil. Mach7 Technologies' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Mach7 Technologies (ASX:M7T), the current EBIT is A$-23.82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?

Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued. The current stock price of A$0.31 is trading 62.8% below its estimated GF Value™ of A$0.82. GuruFocus considers Mach7 Technologies to be Possible Value Trap.

Key valuation signals for ASX:M7T:

  • EBIT: A$-23.82 Mil
  • GF Value™: A$0.82 vs. price of A$0.31 (62.8% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mach7 Technologies Business Description

Other Exchanges TDMMF:USA
Address 120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score

Get the complete analysis for ASX:M7T

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.31
Price
A$0.82
GF Value